STOCK TITAN

Arvinas Board Member Gets Major Equity Incentive as Company Builds Long-term Leadership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Arvinas Director Everett Cunningham received significant equity compensation on June 25, 2025, consisting of two key components:

  • 16,025 Restricted Stock Units (RSUs) granted at $0, increasing total direct common stock ownership to 26,045 shares
  • 23,105 Stock Options with exercise price of $7.80, expiring June 24, 2035

Both the RSUs and stock options will fully vest on the earlier of June 25, 2026 or the first board meeting following the next annual stockholder meeting, contingent on Cunningham's continued service. The RSUs represent rights to receive common stock at no cost upon settlement, while the options provide purchase rights at the specified strike price. This compensation structure aligns the director's interests with long-term shareholder value.

Positive

  • None.

Negative

  • None.
Insider Cunningham Everett
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 23,105 $0.00 --
Grant/Award Common Stock 16,025 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 23,105 shares (Direct); Common Stock — 26,045 shares (Direct)
Footnotes (1)
  1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cunningham Everett

(Last) (First) (Middle)
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.

(Street)
NEW HAVEN CT 06511

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/25/2025 A 16,025(1) A $0 26,045 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $7.8 06/25/2025 A 23,105 (2) 06/24/2035 Common Stock 23,105 $0 23,105 D
Explanation of Responses:
1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
2. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
Remarks:
/s/ Jared Freedberg, as attorney-in-fact for Everett Cunningham 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock compensation did ARVN director Everett Cunningham receive on June 25, 2025?

Everett Cunningham received two forms of stock compensation on June 25, 2025: (1) 16,025 restricted stock units (RSUs) that vest in full on June 25, 2026 or the first board meeting after the next annual stockholder meeting, and (2) stock options to purchase 23,105 shares at $7.80 per share, which vest on the same schedule.

When do Everett Cunningham's ARVN stock options expire?

The stock options granted to Everett Cunningham on June 25, 2025 expire on June 24, 2035, giving them a 10-year term from the grant date.

How many shares of ARVN common stock does Everett Cunningham own directly after the June 25, 2025 grant?

Following the reported transaction, Everett Cunningham directly owns 26,045 shares of ARVN common stock, as indicated in Table I of the Form 4 filing.

What is the vesting schedule for ARVN director Cunningham's June 2025 RSU grant?

The RSUs will vest in full on the earlier of either June 25, 2026 or the first board of directors meeting held after the next annual stockholders meeting, subject to Cunningham's continued service with Arvinas.

What was the exercise price of the stock options granted to ARVN's director Cunningham?

The stock options were granted with an exercise price of $7.80 per share, as shown in Table II of the Form 4 filing.